The Patent Finder

Pulmokine, Inc.

Also on record
Records under this name other than the patents Pulmokine, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 5 of 5 · Back to Pulmokine, Inc.

PatentTitleStatus Expires Confidence
14/760,165Therapeutic Indications of Kinase Inhibitors
Abandoned
Abandoned Nov 13, 2017
AbandonedAbandoned Nov 13, 2017
15/809,054Spray Dry Formulations
Abandoned
Abandoned Oct 29, 2019
AbandonedAbandoned Oct 29, 2019
16/256,213Combination Therapy for Treating Pulmonary Hypertension
Abandoned
Abandoned Sep 23, 2019
AbandonedAbandoned Sep 23, 2019
16/968,530Formulations of Kinase Inhibitors and Prostanoids
Abandoned
Abandoned Jul 8, 2024
AbandonedAbandoned Jul 8, 2024
18/628,470Formulations of Kinase Inhibitors and Prostanoids
Abandoned
Abandoned Jun 8, 2026
AbandonedAbandoned Jun 8, 2026
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited